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Abstract
Background: A major consequence of stroke is permanent motor disturbance, such as postural imbalance and loss
of skilled movement. The degree of neuronal and functional loss and subsequent recovery after stroke is
influenced by hypothalamic-pituitary-adrenal axis activation and the response to glucocorticoid hormones. This
study investigated if recovery after stroke is related to glucocorticoid receptor (GR) activation in a rat model of
stroke.
Methods: Adult male rats were pre-trained and tested in a skilled reaching task and received a focal ischemic
motor cortex lesion. One group of animals received daily restraint stress starting one week pre-lesion up to three
weeks post-lesion. Immuno-histochemical analysis of GR expression was performed to determine receptor
activation.
Results: Stress reduced reaching success in naïve animals and diminished recovery of limb use. Exaggerated
functional loss in stressed rats was related to increased GR activation in the lesion hemisphere as indicated by
nuclear GR location.
Conclusion: These findings provide a mechanistic link between stress-induced motor disability and GR activation
in a rat model of stroke. The elevated receptor activation proposes synergistic effects of stress and stroke to
modulate the impact of glucocorticoids on motor system function at the genomic level. The modulation of GR
biosynthesis may alter responsiveness to stroke treatment and compromise recovery.
Introduction
Common symptoms of stroke include motor distur-
bances, such as postural imbalance and disturbed skilled
movement [1-3]. The degree of spontaneous functional
recovery after stroke is determined by inflammatory
processes, which are modulated by stress and activity of
the hypothalamic-pituitary-adrenal (HPA) axis [4].
Stress and high levels of glucocorticoids (GCs) are
associated with poor stroke outcome and high morbidity
[5-8]. The experience of psychological distress is asso-
ciated with increased stroke risk and represents a pre-
dictor of fatal stroke [9-13]. Stress has been recognized
as a critical variable in determining the success of stroke
therapy and rehabilitative interventions [14,15]. Because
adverse experience modulates neuronal plasticity [16,17]
the intrinsic properties of the HPA axis, such as GR
density, may explain the large variability in recovery
rates among individual patients [18]. Because GC ther-
apy also represents a potential treatment for stroke,
investigation of glucocorticoid receptor (GR) regulation
is critical to explore potential therapeutic avenues.
This study describes the effects of psychological stress
on GR expression and activation, and its impact on
recovery and outcome after ischemic lesion in a rat
model. The findings suggest that stress-induced regula-
tion of GR expression after ischemic stroke may influ-
ence HPA axis feedback mechanisms.
Materials and methods
Animals
Twenty-two adult male Long-Evans rats (400-500 g)
raised at the University of Lethbridge vivarium were
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any medium, provided the original work is properly cited.used. For participation in skilled reaching, animals were
food restricted to maintain 90-95% of baseline body
weight. Animals were matched to two groups based on
baseline reaching success: Stress (n = 11), and handled
Controls (n = 11). All procedures were performed in
accordance with the guidelines of the Canadian Council
for Animal Care and approved by the local Animal Wel-
fare Committee.
Motor cortex lesion
Rats were anesthetized using isoflurane in an oxygen/
nitrous oxide mixture (isoflurane 4% for initiation, 2%
for maintenance at an oxygen flow rate of 2.0 l/min).
Motor cortex devascularization was induced contralat-
eral to the paw preferred in skilled reaching [19]. Briefly,
the skin over the skull was incised and the skull was
exposed. Using a fine dental burr, a craniotomy was per-
formed at the following coordinates: -1.0 to 4.0 mm
anterior-posterior, 1.5 to 4.5 mm lateral to Bregma. The
dura and blood vessels were carefully wiped off using a
sterile cotton tip. The skin was sutured and the rats
were given analgesic (Temgesic, Schering-Plough, Brus-
sels, Belgium). Rats were allowed to recover in indivi-
dual cages on a heating pad until fully awake and were
then returned to their home cages.
Stress paradigm
The stress regimen was performed 7 days prior, and 21
days after motor cortex lesion. Rats were placed indivi-
dually in a transparent Plexiglas cylinder [20-22]. The
cylinder (5 cm inner diameter) had perforated ends to
allow for ventilation and maintained the animals in a
standing position without compression of the body.
Restraint stress was given starting at 9:00 AM. Animals
were restrained for 20 minutes and were tested 10 min-
utes later in the skilled reaching task [23,24,21,25].
Furthermore, on the last day of baseline (pre-stress) and
after 3 weeks of post-lesion behavioural tests, blood
samples were collected after a 10 minute post-stress
interval. Thus, both behavioural testing and blood sam-
pling took place at a time when elevated corticosterone
levels after restraint stress can be expected [21,23].
Skilled reaching task
The rats were trained in the single pellet reaching task
to assess skilled forelimb function [26,27] (Figure 1A).
The reaching boxes were made of clear Plexiglas (40 cm ×
45 cm × 13 cm). The front wall of the box had a 1.3 cm
wide vertical slit, allowing the rats to reach for a food
pellet located on a shelf attached to the outside of the
box. The shelf was located 4 cm above the floor. On
top of the shelf were two indentations (5 mm in dia-
meter, and 1.5 mm deep), each aligned with one side
of the slit. These indentations stabilized the pellet and
were located 1.5 cm away from the front wall [27]. In
each training session, rats were placed individually in
the reaching box and a food pellet (45 mg each, Bio-
Serv, Frenchtown, NJ) was placed contralaterally to the
rats’ preferred reaching paw. To readjust their body
position, rats were trained to walk to the rear end of
the box before reaching for a new pellet. Each rat was
given 20 pellets per training and test session.
A successful reach was defined as obtaining the pellet
on the first attempt, withdrawing the paw through the
slit and releasing the pellet to the mouth. Success was
calculated using the following formula:
Percentage of reaching success 
number of successful reach
=
e es
20
100 ×
The percentage of total number of pellets obtained
was measured by counting the number of pellets eaten,
regardless of whether the pellet was grasped and eaten
on the first attempt. If the rat dropped the pellet, it did
not count as a pellet eaten. The percentage of total pel-
lets obtained was measured using the following formula:
Percentage of total pellets obtained
number of pellets obt
=
a ained
20
100 ×
To assess reaching accuracy, the number of attempts
to grasp a single pellet was averaged.
Once reaching success rates during training sessions
reached an asymptotic level, performance was recorded
for 5 days of baseline testing. These values were aver-
aged for further analysis (pre-stress). After the start of
the stress regimen animals were tested in skilled reach-
ing for 7 days prior and for 21 days after lesion.
Blood samples
Blood samples were taken from the tail vein on the last
day of baseline (pre-stress), and three weeks post-lesion
(the day before sacrifice). An average of 0.6 ml of blood
was collected 10 minute post-stress interval under 4%
isoflurane anesthesia. Blood samples were collected
between the hours of 9:10-10:30 AM. No behavioural
testing was performed on days on which blood samples
were taken. Plasma corticosterone concentrations were
determined by radioimmunoassay using commercial kits
(Coat-A-Count, Diagnostic Products Corp., Los Angeles,
CA) [28].
Histology and immunohistochemistry
After completion of behavioural tests, rats were
sacrificed with an overdose of pentobarbital (Euthansol;
CDMV Inc. Québec, Canada) and transcardially
perfused with phosphate buffered saline followed by 4%
formaldehyde. Brains were cut at 10 μm thickness.
Forty-five sections per brain were cut in each of the
anterior lesion site, the middle section and the posterior
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immuno-histochemical analysis.
Infarct volume
Cresyl Violet stained brain sections (10 μm) were used
to analyze infarct volume. Cross-sectional volumes of
both hemispheres were calculated using a Zeiss Axiovi-
sion 4.3 microscope (Zeiss, Jena, Germany). Infarct
volume was measured according to the Cavalieri method
[29]. The following formulas were used (VH: volume of
a hemisphere; VTL: volume of tissue lost):
VH  average  average area of a complete coronal hemisphere  = – ––  ventricles   area of damage
   interval between sectio
( )
× n ns   number of sections ×
VTL  tissue remaining in normal hemisphere   tissue remain = –i ing in injured hemisphere
Immunostaining
Serial coronal sections were incubated overnight in
p r i m a r ya n t i b o d yr a b b i ta n t i - G R( S a n t aC r u zB i o t e c h ;
1:50). Controls were performed omitting the primary
antibody. Sections were incubated with a secondary
anti-rabbit biotinylated antibody (Vectastain ABC Kit:
peroxidase rabbit IgG, 1:200), which was detected
using the Elite ABC-peroxidase kit (Vectastain ABC
Kit, Vector) with DAB as chromogen (according to
[30,31] but modified). Sections were examined under
light microscopy.
Quantitative analysis of GR expression and activation
Photographs were captured digitally and panoramic
pictures (1× lens) from coronal brain sections were
taken (Figure 2A). Three motor cortex areas in the
lesion and non-lesion hemispheres were photographed
(40×; Figure 3A1-A4). GR expression was measured
using ImageJ software (NIH, Bethesda, Maryland, USA).
Color images were converted to monochromatic photo
images to determine mean gray scale values.
GR activation was quantified by selecting the cellular
stained nucleus (according to [32-34] but modified).
Cellular location of GR was analyzed semi-quantitatively
(100× lens; Figure 3B1, B2).
Statistical analysis
Statview software version 5.0 (SAS Institute, 1998) was
used to perform analyses of variance (ANOVA), unpaired
student t-tests for between-group comparisons and
Figure 1 Stress induces motor impairments.( A ) ,p h o t o g r a p ho far a tr e a c h i n gf o raf o o dp e l l e t. (B), success percent; (C), pellets obtained
percent; (D), number of attempts to grasp 20 pellets. All data are presented as group means + SEM. * p < 0.05, ** p < 0.01, *** p < 0.001,
compared to the Control group.
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pellet reaching task, and for GR expression patterns
across hemispheres. A p-value of less than 0.05 was
chosen as significance level. All data are presented as
mean ± standard error of the mean.
Results
Skilled reaching
Reaching success
There was a significant difference in the success rate
between groups (F(1,28) = 56.34, p < 0.001). Stress
Figure 2 Chronic stress activates the stress response in absence of GR density alteration. (A), Coronal brain section showing GR immune-
histochemistry; (B), total GR quantification; (C), plasma corticosterone levels (CORT). All data are presented as group means ± SEM. * p < 0.05,
compared to the Control group.
Figure 3 Stress modulates GR activation after ischemic lesion.( A ) ,G Rn u c l e a rd e n s i t y ;( B ) ,G Rn u c l ear translocation. Lesion increased
activated GR density in the lesion hemisphere compared to the non-lesion hemisphere in stress (A1 and A3) and control (A2 and A4) groups.
Stress increased GR activation in the lesion hemisphere (A1) when compared to the non-lesion hemisphere (A3) (*p < 0.05). GR is constitutively
expressed in the cytoplasm (arrow in B2), and inactive as a GR-HSP complex. GC enters the cell and binds to a GR dissociating the GR-HSP
complex (Schema B3). Consequently, GR is activated when a GR-GC dimer is formed and translocated into the nucleus (arrow in B1; schema B3).
Scale bars: 10 μm.
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animals (pre-lesion stress: day 1, t(21) = -3.80, p < 0.001;
day 2, t(21) = -5.58, p < 0.001; day 3, t(21) = -5.58,
p < 0.001; day 4, t(21) = -4.84, p < 0.001; day 5, t(21) =
-5.72, p < 0.001; day 6, t(21) = -4.45, p < 0.001; day 7,
t(21) = -3.48, p < 0.01; post-lesion stress: day 15, t(21) =
-2.91, p < 0.01; day 16, t(21) = -2.14, p < 0.05; day 17,
t(21) = -2.94, p < 0.01; day 20, t(21) = -2.63, p < 0.05; day
21, t(21) = -2.28, p < 0.05; Figure 1B). There was a
decline from baseline to post-lesion testing in Stress
animals, and from pre-lesion to post-lesion in Control
animals (Stress: t(10) = 10.22, p < 0.001, t(10) = 5.14,
p < 0.001; Control: t(11) = 10.77, p < 0.001).
Number of pellets obtained
There was significant difference in the number of pellets
obtained between groups (F(1,28) = 21.71, p < 0.001).
The Stress group showed a decrease on days 2, 3, 4 and
5 pre-lesion when compared to Controls [day 2: t(21) =
-4.36, p < 0.001; day 3: t(21) = -3.48, p < 0.01; day 4:
t(21) = -2.52, p < 0.05; day 5: t(21) = -3.02, p < 0.01;
(Figure 1C)]. Performance decreased from baseline to
pre-lesion in Stress animals, and from pre-lesion to
post-lesion in Controls (Stress: t(10) = 4.56, p < 0.001;
Control: t(11) = 5.93, p < 0.001).
Number of Attempts
Overall there was a significant group difference in the
number of attempts to grasp a food pellet (F(1,28) =
17.14, p < 0.001). Stress animals made more attempts
than Controls on all pre-lesion days and days 6 and 15
post-lesion (pre-lesion: day 1, t(21) = 2.42, p < 0.05;
day 2, t(21) = 3.59, p < 0.01; day 3, t(21) = 3.57,
p < 0.01; day 4, t(21) = 3.61, p < 0.001; day 5, t(21) =
5.56, p < 0.001; day 6, t(21) = 3.87, p < 0.001; day 7,
t(21) = 5.83, p < 0.001; post-lesion: day 6, t(21) = 2.08,
p < 0.05; day 15, t(21) = 2.57, p < 0.05; Figure 1D).
Controls made more attempts after lesion than pre-
lesion (t(11) = -5.27, p < 0.001). Stress animals made
more attempts pre-lesion than at baseline (t(10) =
-4.92, p < 0.001).
Infarct size
The lesion included the primary and secondary motor
cortex as well as the forelimb and hind limb areas of
somatosensory cortex (Figure 2A). There was no signifi-
cant difference in infarct size between groups. The Stress
group lost on average 18.02 mm
3 of tissue and the Con-
trol group lost on average 12.14 mm
3 of tissue. There
was no correlation between infarct size and skilled
reaching success (r = 0.37).
Plasma corticosterone
The Stress group had higher plasma corticosterone
(CORT) levels compared to Controls post-lesion (t(21) =
2.81, p < 0.05; Figure 2C).
Glucocorticoid receptor expression
Stress animals showed slightly lower total GR expression
than Controls (Figure 2B). There was higher GR
activation in the lesion hemisphere in Stress animals
when compared to the non-lesion hemisphere (t(7) =
3.43, p < 0.05; Figure 3A1-A3). There was slightly higher
GR activation in the lesion hemisphere of Stress animals,
and lower GR activation in the non-lesion hemisphere,
when compared to Control animals (Figure 3A).
Semi-quantitative analysis allowed the discrimination
between nuclear (Figure 3B1) and cytoplasm (Figure
3B2) GR sub-location. GR nuclear density was increased
near the lesion site.
Discussion
The present findings provide a mechanistic link between
stress-induced motor disability and biochemical changes
in a rat model of stroke. At the behavioural level, stress
diminished skilled limb use in naïve rats and hindered
motor recovery from an ischemic infarct thus confirm-
ing previous studies [35,21,24,25,36,37]. Furthermore,
chronic stress increased circulating corticosterone con-
centrations. At the molecular level, chronic restraint
stress modulated GR activation of central motor systems
that cause permanent alterations in GC susceptibility.
These findings support the notion that stress drives bio-
chemical changes that are accompanied by lasting func-
tional loss.
The main finding of the present study revealed an
additive effect of stress and stroke to enhance GR acti-
vation in the lesion hemisphere. While enhanced GR
activation occurred without concomitant changes in
infarct size, diminished recovery in these animals sug-
gests that elevated GC levels are detrimental to func-
tional outcome. Stroke can induce an inflammatory
response in the brain, what might affect the immune-
endocrine communication, such as GC levels, causing
the alteration of essential biological functions. Although
corticosteroids may represent a potential treatment for
ischemic cerebral edema [38], even physiologically ele-
vated GC levels may modulate edema formation and
recovery after ischemic infarct [24,36]. The latter studies
suggest that chronic stress and associated immuno-
endocrine interactions may promote disease aggravation.
These observations are not surprising given the large
body of evidence documenting central GC effects.
Elevated GC levels may promote pro-inflammatory cell
migration, cytokine production, and transcription factor
activity in the brain [4] resulting in necrotic cell death
[39].
High GC levels render neurons more susceptible to
neurological insults via disruption of anti-apoptotic
factor [40] and neurotrophic factor expression
[15,41,42]. GC-mediated regulation of these factors
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plasticity and the capacity to compensate for functional
loss [24,37].
In human acute stroke the GC component of the
stress response can be harmful, at least when cortisol
reaches high blood concentrations within the first days
after stroke to exaggerate ischemic injury and neuronal
death [12]. Furthermore, corticosteroid treatment has
been shown to be ineffective for some survivors from
acute ischemic stroke [44]. The concert of anti- versus
pro-inflammatory effects of GCs complicates the inter-
pretation of clinical trials.
The mechanism of action of GCs is through its bind-
ing with the type I mineralocorticoid receptor (MR) and
the type II GR [45]. MRs are mostly occupied by GCs at
basal levels [46]. GRs have low affinity for GCs and
become occupied at the time of stress-induced GC ele-
vation. GRs typically reside in the cytoplasm of the cell,
bound to chaperone heat shock proteins until GCs enter
the cell. Upon ligand binding the GR-GC complex is
released from the chaperone complex to translocate to
the cell nucleus (see Figure 3B3). Once in the nucleus,
the GR-GC complex binds to the DNA, influencing
transcription [47,48]. These changes may be directly
linked to lasting alterations in brain function and stroke
outcome.
Enhanced GR activation in the lesion hemisphere sug-
gests altered sensitivity of the HPA axis induced by
stress. GRs are involved with reactive feedback to
restore disturbed homeostasis [49]. Modulatory influ-
ences of GR, such as GC negative feedback, may dam-
pen the HPA response [50]. Once GCs induce neuronal
loss, low GR density could reduce the HPA axis negative
feedback, thus promoting further GC production
[51,52].
The balance of MR- and GR-mediated effects exerted
by GCs is critical for homeostatic control [53]. Here we
found increased GR activation in the lesion hemisphere,
suggesting effective negative HPA feedback regulation
that confines deleterious effects of stress to protect or
promote neuronal survival. This notion is supported by
considerable motor recovery in the absence of exagger-
ated infarct size after stress.
Additional to central regulation of the stress response,
GRs are critical for physiological sustainability. GRs
modulate synaptic plasticity associated with the plas-
matic membrane acting through second messengers to
regulate signal transduction cascades [54]. Increased GR
expression in the lesion hemisphere could therefore pro-
mote plasticity and maintain integrity of existing path-
ways thus facilitating compensation after stroke.
Since GC therapy represents a treatment option for
clinical stroke to contain inflammatory processes, the
investigation of the role of stress and lesion in GR
regulation is critical to explore future therapeutic
avenues. The current findings suggest that one possible
mechanism to affect stroke outcome is brain GR modula-
tion, and consequent alteration of stress responsiveness
and GC therapy. The investigation of GR regulation there-
fore is a critical step towards designing effective therapies
and rehabilitation strategies for stroke survivors.
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